AstronauTx completes £48m series A financing for Alzheimer’s disease by Jen Brogan | Oct 12, 2023 | News | 0 The financing will support the biotech’s clinical study of people with AD as a lead programme Read More
UK’s Enterprise Therapeutics raises £29m by Selina McKee | Apr 12, 2018 | News | 0 Brighton, UK-based Enterprise Therapeutics has raised £29 million to help it advance its experimental therapies for respiratory diseases. Read More